Workflow
和元生物: 关于董事会提前换届选举的公告

Core Viewpoint - The company, He Yuan Biotechnology (Shanghai) Co., Ltd., is preparing for an early board of directors election as the current term will expire in September 2025, in accordance with relevant laws and regulations [1][2]. Board Election Summary - The fourth board of directors is proposed to consist of 9 members, including 5 non-independent directors (1 employee representative) and 4 independent directors [1]. - The board has nominated candidates for the fourth board, including Pan Oudong, Yin Shan, Pan Junyi, and Wang Fujie as non-independent directors, and Gao Guolei, Hao Mei, Wu Danfeng, and Hou Xuchao as independent directors [1][2]. - The independent director candidates must be approved by the Shanghai Stock Exchange before being submitted for shareholder meeting review [2]. - The second extraordinary general meeting of shareholders in 2025 will vote on the board election, with cumulative voting for both non-independent and independent directors [2]. Other Information - The current board has been diligent and contributed positively to the company's operations and development [3]. - The candidates for the board have met the qualifications required by relevant laws and regulations, and none are disqualified from serving as directors [2][3].